69f73cc3_anderbilt_Ingram_Cancer_Center__Trial_Type
[Protocol No. & Open Date] CTSUUROS1216-M 01/16/2014 [Summary] A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer [Trial Type] 
Treatment Prostate
Urologic / Genitourinary Cancers - Vanderbilt-Ingram Cancer Center
Trial Type